1. Home
  2. CMND

as of 02-13-2026 11:58am EST

$1.18
+$0.09
+8.26%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Founded: 2017 Country:
Canada
Canada
Employees: N/A City: N/A
Market Cap: 4.0M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 449.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -30.35 EPS Growth: N/A
52 Week Low/High: $1.05 - $58.00 Next Earning Date: 03-12-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: N/A Index: N/A
Free Cash Flow: -4734498.0 FCF Growth: N/A

AI-Powered CMND Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 80.65%
80.65%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Clearmind Medicine Inc. News

CMND Breaking Stock News: Dive into CMND Ticker-Specific Updates for Smart Investing

All CMND News

Share on Social Networks: